2001
DOI: 10.1139/bcb-79-1-21
|View full text |Cite
|
Sign up to set email alerts
|

Human growth factor receptor bound 14 binds the activated insulin receptor and alters the insulin-stimulated tyrosine phosphorylation levels of multiple proteins

Abstract: To identify proteins interacting in the insulin-signaling pathway that might define new pathways or regulate existing ones, we have employed the yeast two-hybrid system. In a two-hybrid screen of a human liver cDNA library, we identified the human growth factor receptor bound 14 (hGrb14) adaptor protein as a partner of the activated insulin receptor. Additional analysis of the insulin receptor--hGrb14 interaction in the yeast two-hybrid system revealed that the SH2 domain of hGrb14 was not the sole region invo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
13
0

Year Published

2004
2004
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(14 citation statements)
references
References 0 publications
1
13
0
Order By: Relevance
“…This involves a non-competitive mechanism with an order of potency Grb14 > Grb10 > Grb7, and IR activity more potently inhibited than IGFR activity [97]. Consistent with these in vitro effects, over-expression of Grb10 [81,92,[103][104][105] and Grb14 [38,94,97] in cells inhibits insulin-and/or IGF-1-stimulated tyrosine phosphorylation of endogenous substrates (IRS1, IRS2, Shc and p62Dok). Conversely, depletion of endogenous Grb10 by small interfering RNA (siRNA) interference potentiates insulin/IGF-induced substrate phosphorylation [81,103,106,107].…”
Section: Effects Of Grb7/10/14 On Insulin and Igf-1 Receptor Kinase Amentioning
confidence: 66%
See 1 more Smart Citation
“…This involves a non-competitive mechanism with an order of potency Grb14 > Grb10 > Grb7, and IR activity more potently inhibited than IGFR activity [97]. Consistent with these in vitro effects, over-expression of Grb10 [81,92,[103][104][105] and Grb14 [38,94,97] in cells inhibits insulin-and/or IGF-1-stimulated tyrosine phosphorylation of endogenous substrates (IRS1, IRS2, Shc and p62Dok). Conversely, depletion of endogenous Grb10 by small interfering RNA (siRNA) interference potentiates insulin/IGF-induced substrate phosphorylation [81,103,106,107].…”
Section: Effects Of Grb7/10/14 On Insulin and Igf-1 Receptor Kinase Amentioning
confidence: 66%
“…First detected by yeast two-hybrid and glutathione S-transferase (GST) pull-down assays, interactions of Grb7 [87], Grb10 [27,36,[88][89][90][91][92][93] and Grb14 [12,38,94] with IR and of Grb10 with IGFR [36,91,93,95,96] have been demonstrated by co-immunoprecipitation and bioluminescence resonance energy transfer of over-expressed proteins in CHO, COS and HEK293 cells. Endogenous Grb14 also associates with ligandactivated IR in 3T3L1 adipocytes and rat liver [38,57] and with light-activated IR in rat retina [21].…”
Section: Association Of Grb10/14 With Activated Insulin and Igf-1 Recmentioning
confidence: 99%
“…On the basis of the crystal structure of the tyrosine kinase domain of the IR in complex with the PIR ⁄ BPS domain of Grb14, Depetris et al [8] have shown that Grb14 binds as a pseudosubstrate inhibitor to the peptide-binding groove of the kinase and thus acts as a selective inhibitor of insulin signaling. Consistent with this observation, overexpression of Grb14 in CHO-IR cells impairs Akt and ERK insulin signaling pathways and inhibits distal effects of insulin on glycogen and DNA synthesis [6][7][8][9], and microinjection of Grb14 into Xenopus laevis oocytes inhibits insulin-induced oocyte maturation [10]. Conversely, disruption of the Grb14 gene in mice ameliorates glucose tolerance in vivo and insulin signaling in both liver and skeletal muscle [11].…”
mentioning
confidence: 59%
“…In human and mammals, GRB14 mRNA was found to be expressed at high level in the ovary, liver, kidney, skeletal muscle and so on [25], [26]. It interacts with insulin receptors (IR) and insulin-like growth-factor receptors (IGFR), and may play an inhibiting role in tyrosine kinase receptor (Tkr) signaling pathways [27], [28]. IGF and IGFR were reported to regulate ovarian functions and follicular developments in chickens [29], [30].…”
Section: Discussionmentioning
confidence: 99%